AI Analysis

How does NECLIFE.NS make money? Does NECLIFE.NS have pricing power? What's the Earnings Whisper? Will NECLIFE.NS profit more as the business scales? What is NECLIFE.NS's management track record? Is NECLIFE.NS's current price justified?

Nectar Lifesciences Limited

₹10.54 -$9.84 (-48.28%)

NSE · 16 Oct 2026 09:55 UTC

Previous Close

₹10.04

Day Range

₹10.1₹10.54

Year Range

₹9.3₹22.4

Market Cap

2.05B

AVG Volume

185.25K

Trailing/Forward PE

-0.93/-

PEG ratio

0.01

Dividend Yield

Next Earnings Date

Primary Exchange

National Stock Exchange of India

Revenue (INR) · Q

NECLIFE.NS Revenue (INR) by quarter
Period	Revenue (INR)
27 Q1	4.42M
26 Q4	12.9M
26 Q3	0
26 Q2	57.11M
26 Q1	2.81B
25 Q4	4.29B
25 Q3	4.54B
25 Q2	4.28B
25 Q1	3.59B
24 Q4	4.4B

Net Income (INR) · Q

NECLIFE.NS Net Income (INR) by quarter
Period	Net Income (INR)
27 Q1	-153.98M
26 Q4	-679.24M
26 Q3	142.7M
26 Q2	-1.76B
26 Q1	-632.31M
25 Q4	-1.3B
25 Q3	78.4M
25 Q2	55.99M
25 Q1	29.69M
24 Q4	5.92M

Operating Income (INR) · Q

NECLIFE.NS Operating Income (INR) by quarter
Period	Operating Income (INR)
27 Q1	-273.82M
26 Q4	-573.18M
26 Q3	-19.87M
26 Q2	-5.32M
26 Q1	-784.09M
25 Q4	-1.7B
25 Q3	290.96M
25 Q2	277.85M
25 Q1	243.43M
24 Q4	338.05M

EBITDA · Q

Cash Flows · Q

EPS · Q

Expenses · Q

Cash & Debt · Q

Debt ratios · Q

Margins · Q

Return on Capital · Q

Shares Outstanding · Q

Dividends (INR) · Q

Employee Count

Book Value Per Share · Q

Total Assets · Q

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Nectar Lifesciences Limited

Video analysis: NECLIFE.NS

News: NECLIFE.NS

Similar companies